✦ LIBER ✦

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the childrens cancer group

✍ Scribed by Lawrence J. Ettinger; Paul S. Gaynon; Mark D. Krailo; Ning Ru; Edward S. Baum; Stuart E. Siegel; G. Denman Hammond

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 442 KB
Volume: 73
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19940215)73:4<1297::aid-cncr2820730427>3.0.co;2-#

No coin nor oath required. For personal study only.

✦ Synopsis

Background. Carboplatin is an analogue of cisplatin with less nonhematologic toxicity than

📜 SIMILAR VOLUMES

Carboplatin in childhood brain tumors: A

Carboplatin in childhood brain tumors: A children's cancer study group phase II trial

✍ Paul S. Gaynon; Lawrence J. Ettinger; Edward S. Baum; Stuart E. Siegel; Mark D. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 1 views

A Phase II study of carboplatin as a tre

A Phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow : A report of the Children's Cancer Group

✍ Lawrence J. Ettinger; Percy Ivy; Paul S. Gaynon; Alice G. Ettinger; Wen Liu-Mare 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## BACKGROUND. Carboplatin is an analogue of cisplatin with less nonhematologic toxicity

Tumors of the pineal and suprasellar reg

Tumors of the pineal and suprasellar region: Childrens cancer study group treatment results 1960–1975. A report from childrens cancer study group

✍ William M. Wara; Derek T. Jenkin; Audrey Evans; Inta Ertel; Robert Hittle; Jorge 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 1 views

A Phase I study of granulocyte-macrophag

A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors : A report of the Children's Cancer Group

✍ Mitchell S. Cairo; Mark D. Krailo; Joel A. Weinthal; Rita Secola; Sharon Bergero 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

## Background: This phase i trial was developed to determine the safety, biologic activity, and effects on hematopoietic recovery of pixy321 following ifosfamide, carboplatin, and etoposide chemotherapy for children with recurrent or refractory solid tumors. ## Methods: Children (age < 22 years a

A dose-intensive, cyclophosphamide-based

A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/Progressive or advanced solid tumors of childhood : A report from the Australia and New Zealand Children's Cancer Study Group

✍ Paul A. Carpenter; Les White; Geoffrey B. McCowage; Vimala Nayanar; Ian Toogood; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

promising salvage regimen. Continued accrual of patients and increased duration of follow-up has resulted in substantial experience with VETOPEC.

Treatment of children with stage IV favo

Treatment of children with stage IV favorable histology Wilms tumor: A report from the National Wilms Tumor Study Group

✍ Green, Daniel M.; Breslow, Norman E.; Evans, Ilonka; Moksness, Jami; D'Angio, Gi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB

The purpose of this study was to evaluate the effect of the sequential addition of doxorubicin and cyclophosphamide to the combination of vincristine and actinomycin D o n the relapse-free survival of children with stage IV/favorable histology Wilms tumor. We reviewed the clinical courses of all ran